Earn the trust before the refill.
The wedge is here now. We build de-identified cohorts from verified real-world data and reach them on streaming, so your brand is the one a patient already knows.
Healthcare, next
Be the brand patients trust.
The GLP-1 surge moved a generation of patients into the market at once. One brand will own the answer they get when they ask the machine who to trust. We earn that answer, build the brand behind it, and carry it to the screens they actually watch.
Check my marketThe read
We plan to a cohort and measure to an outcome.
- CohortAudiences built de-identified, never one person
- HIPAACertified audiences from verified real-world data
- 210DMAs we monitor, market by market
- 24MSmart-TV households in the panel
Audiences are de-identified. We never target a person and never promise a patient count · SOURCE: market panel + search data · TAQTICS STUDIES
The problem
Metabolic brands all sound the same.
Same promise. Same stock smile. Same hopeful headline. Patients are searching for who to believe, and most brands blend into one another. We find the open lane, build a brand a patient remembers, and carry it where they spend their evenings. Marketing economics, never clinical advice. That line we don't cross.
Move before the category fills.
The same playbook carries into the next person-first health category. We track where attention is moving so your brand is live before the lane gets crowded.
One seat per market. Then it's closed.
Same trust bar as legal, higher stakes. We arm one brand per category per market, never two rivals. Check whether yours is still open.
Check my market